News
-
-
-
PRESS RELEASE
EQS-Adhoc: Allane SE: Change in the recognition of expenses from an extraordinary depreciation resulting from residual and fair value differences
Allane SE announces change in accounting method for impairment losses on leased assets, leading to lower impairment losses and a positive effect on EBT. Preliminary figures for H1 2024 show consolidated sales of EUR 359.5 million -
-
-
-
-
-
PRESS RELEASE
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
Jaguar Health plans crofelemer approval pathway for breast and lung cancer based on phase 3 results. Join the investor webcast on August 13, 2024, for financial & corporate updates -
